Solvay SA

WBAG:SOLB Stock Report

Market Cap: €3.2b

Solvay Valuation

Is SOLB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SOLB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SOLB (€30.53) is trading below our estimate of fair value (€54.77)

Significantly Below Fair Value: SOLB is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SOLB?

Key metric: As SOLB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SOLB. This is calculated by dividing SOLB's market cap by their current revenue.
What is SOLB's PS Ratio?
PS Ratio0.6x
Sales€5.22b
Market Cap€3.25b

Price to Sales Ratio vs Peers

How does SOLB's PS Ratio compare to its peers?

The above table shows the PS ratio for SOLB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.4x
WIE Wienerberger
0.7x6.8%€3.0b
VOE Voestalpine
0.2x0.4%€3.1b
LNZ Lenzing
0.4x2.7%€1.1b
MMK Mayr-Melnhof Karton
0.4x3.5%€1.4b
SOLB Solvay
0.6x0.2%€3.2b

Price-To-Sales vs Peers: SOLB is expensive based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.4x).

Price to Sales Ratio vs Industry

How does SOLB's PS Ratio compare vs other companies in the European Chemicals Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
SOLB 0.6xIndustry Avg. 1.0xNo. of Companies31PS01.22.43.64.86+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SOLB is good value based on its Price-To-Sales Ratio (0.6x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is SOLB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SOLB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: SOLB is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SOLB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€30.53
€33.19
+8.7%
12.9%€40.00€26.00n/a16
Nov ’25€37.36
€32.63
-12.7%
13.9%€40.00€24.00n/a16
Oct ’25€35.82
€31.94
-10.8%
12.8%€40.00€24.00n/a16
Sep ’25€31.54
€31.63
+0.3%
13.3%€40.00€24.00n/a16
Aug ’25€32.32
€32.16
-0.5%
13.5%€40.00€24.00n/a16
Jul ’25€33.36
€39.28
+17.7%
73.6%€150.00€24.00n/a16
Jun ’25€34.19
€39.28
+14.9%
73.6%€150.00€24.00n/a16
May ’25€30.97
€37.25
+20.3%
79.5%€150.00€20.00n/a16
Apr ’25€24.59
€36.22
+47.3%
82.4%€150.00€20.00n/a16
Mar ’25€23.86
€36.16
+51.5%
82.7%€150.00€20.00n/a16
Feb ’25€25.47
€47.44
+86.2%
82.4%€150.00€22.00n/a16
Jan ’25€27.82
€75.20
+170.3%
69.5%€150.00€22.00n/a15
Dec ’24€107.10
€125.53
+17.2%
16.3%€155.00€84.00n/a15
Nov ’24€100.65
€126.86
+26.0%
15.5%€155.00€84.00€37.3617
Oct ’24€103.50
€127.74
+23.4%
15.2%€155.00€84.00€35.8217
Sep ’24€105.40
€125.53
+19.1%
16.2%€155.00€84.00€31.5417
Aug ’24€110.20
€125.18
+13.6%
16.3%€155.00€84.00€32.3217
Jul ’24€101.00
€124.06
+22.8%
15.9%€150.00€84.00€33.3616
Jun ’24€98.22
€122.33
+24.6%
16.0%€150.00€84.00€34.1915
May ’24€108.30
€121.53
+12.2%
16.1%€150.00€81.00€30.9715
Apr ’24n/a
€121.53
0%
16.1%€150.00€81.00€24.5915
Mar ’24n/a
€117.73
0%
15.1%€145.00€81.00€23.8615
Feb ’24€107.55
€115.80
+7.7%
16.3%€145.00€81.00€25.4715
Jan ’24€95.60
€112.00
+17.2%
16.8%€145.00€81.00€27.8216
Dec ’23€93.84
€112.00
+19.4%
16.8%€145.00€81.00€107.1016
Nov ’23€91.12
€108.88
+19.5%
16.8%€145.00€71.00€100.6517

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

ArcelorMittal

€18.1b

Operates as integrated steel and mining companies in the United States, Europe, and internationally.

MT

€23.14

7D

-1.6%

1Y

3.1%

Freeport-McMoRan

US$63.8b

Engages in the mining of mineral properties in North America, South America, and Indonesia.

FCX

US$41.44

7D

0.7%

1Y

22.4%

Aluminum Corporation of China

HK$126.2b

Primarily engages in the exploration and mining of bauxite, coal, and other resources in the People's Republic of China and internationally.

AOC

HK$0.58

7D

-3.2%

1Y

28.5%